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Abstract
A collaborative exercise on DNA methylation-based body fluid identification was conducted by seven laboratories. For this project, a multiplex methylation SNaPshot reaction composed of seven CpG markers was used for the identification of 4 body fluids, including blood, saliva, semen and vaginal fluid. A total of 30 specimens were prepared and distributed to participating laboratories after thorough testing. The required experiments included four increasingly complex tasks: 1) capillary electrophoresis of a purified single-base extension reaction product, 2) multiplex PCR of bisulfite-modified DNA, 3) bisulfite conversion of genomic DNA and 4) extraction of genomic DNA from body fluid samples. In tasks 2, 3 and 4, one or more mixtures were analyzed, and specimens containing both known and unknown body fluid sources were used. Six of the laboratories generated consistent body fluid typing results for specimens of bisulfite converted DNA and genomic DNA. One laboratory failed to set up appropriate conditions for capillary analysis of reference single-base extension products. In general, variation in the values obtained for DNA methylation analysis between laboratories increased with the complexity of the required experiments. However, all laboratories concurred on the interpretation of the DNA methylation profiles produced.
Although the establishment of interpretational guidelines on DNA methylation-based body fluid identification has yet to be performed, this study supports the addition of DNA methylation profiling to forensic body fluid typing.
This article is protected by copyright. All rights reserved. 
Introduction
Body fluid identification can be of significant importance in solving crimes by assisting the triers of fact in the determination of potential scenarios that may have led to the deposition of evidentiary material [1] . Recently, molecular approaches that permit the detection of specific messenger RNA (mRNA) and micro RNA (miRNA) expression as well as differential DNA methylation patterns have been intensively investigated [2] . Among these, the mRNA-based detection methods have been the most scrutinized, and performance in terms of reproducibility and sensitivity has been well evaluated through a series of large collaborative exercises [2] [3] [4] [5] [6] [7] [8] .
DNA methylation-based body fluid identification has many advantages when compared to mRNA-based methods, such as higher specificity, the ability to be inserted into current forensic DNA-based testing protocols, and the applicability to old cases where only DNA extracts are available [9] . Many CpG markers have been identified which produce differential DNA methylation patterns when extracted DNA from body fluids are compared using genome-wide profiling and gene-specific analysis [10] [11] [12] [13] [14] [15] . Three recent publications [13] [14] [15] are particularly notable for reporting a set of CpG markers that show a methylation signal only in the target body fluids, which can be beneficial to mixed sample analysis. In particular, two earlier studies [13, 14] reported two markers in common; cg17610929, suggested to distinguish semen and cg06379435, for blood. Moreover, further analysis of array data from Electrophoresis This article is protected by copyright. All rights reserved.
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the two studies revealed that they had another blood-specific marker, cg08792630, in common. Because the identification and use of semen-specific CpG markers is not a problem due to the significant difference in DNA methylation between somatic cells and germ cells, further validation studies of CpGs specific to other body fluids, such as vaginal fluid, menstrual blood, saliva etc., would be needed for better application of DNA methylation analysis in forensic caseworks. To detect DNA methylation levels at multiple CpG sites simultaneously, methylation-sensitive restriction enzyme-PCR (MSRE-PCR) and the methylation-sensitive single nucleotide primer extension (SNuPE)-based approach, generally called methylation SNaPshot, have been utilized [10, 14, 15] . In comparison to MSRE-PCR, methylation SNaPshot reactions provide better resolution, and have been adopted in more recent studies [14] [15] [16] .
The present collaborative exercise was organized by Yonsei University College of Medicine in order to evaluate the robustness and reproducibility of DNA methylation profiling for body fluid identification in seven forensic laboratories using kits and chemistries of their own choice and using their own instrumentation. The multiplex methylation SNaPshot reaction used by the collaborative laboratories described in [14] was modified to include seven CpG markers that show a methylation signal only in the target body fluids.
Since the participating laboratories had varying levels of experience, especially with DNA methylation profiling using bisulfite conversion and with the SNaPshot reaction, the goal was to implement the method and compare the interpretational results of DNA methylation profiling from the various laboratories.
Materials and methods
Samples and materials provided
The exercise was divided into four parts such that participants could easily check the success of experiments performed after each step of the consecutive procedures ( Table 1 This article is protected by copyright. All rights reserved.
8
For part 1, the final products from the methylation SNaPshot reaction obtained from one sample each of semen, blood, vaginal fluid and saliva, and two samples from menstrual bloods were prepared as reference materials.
All samples and PCR primer mixtures were thoroughly tested prior to shipment and sent to participating laboratories on dry ice taking from one to four days. When requested, additional reagents such as SNaPshot kit (Applied Biosystems, Foster City, CA, USA) or enzymes necessary for PCR product purification, SBE reaction and purification were sent together on dry ice, and the Imprint™ DNA Modification kit (Sigma-Aldrich, St. Louis, MO, USA) for bisulfite conversion was sent at room temperature.
DNA extraction, DNA quantification and bisulfite conversion
In the organizing laboratory, samples were subjected to DNA extraction, quantification and sodium bisulfite treatment. DNA was extracted from each aliquot of blood, saliva, and semen or from each swab of vaginal fluid and menstrual blood using a QIAamp ® DNA Mini kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. Extracted DNA was quantified using a Quantifiler ® Duo DNA Quantification kit (Applied Biosystems), and 200 ng of genomic DNA was bisulfite converted using the Imprint™ DNA Modification kit and eluted with 20 μL of distilled water. For preparation of specimens to send to collaborative laboratories, an appropriate number of genomic DNA and bisulfite converted DNA batches were pooled and redistributed into 10 μL aliquots, which contained 20 ng/μL of genomic This article is protected by copyright. All rights reserved.
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DNA or approximately 10 ng/μL of bisulfite converted DNA. The specified genomic DNA input in bisulfite conversion of part 3 was 100 ng of genomic DNA, but in part 4, the input amount was not suggested. Example protocols were provided to participating laboratories (Supplementary Material 1) as a reference, but the chemistries and instrumentation to be used were left for each laboratory to decide.
Multiplex methylation SNaPshot
The multiplex methylation SNaPshot reaction described in [14] was modified to include seven CpG markers that show a methylation signal only in the target body fluids. For this study, a blood marker, cg01543184, with cross reactivity to semen was replaced with blood marker cg08792630 [13] , and a semen marker cg17621389 with that produced semen- This article is protected by copyright. All rights reserved.
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cycles of 94˚C for 20 s, 56˚C for 60 s, and 72˚C for 30 s; and a final extension at 72˚C for 7 min. Then, 5 μL of PCR products were purified with 1 μL of ExoSAP-IT (USB, Cleveland, OH, USA) by incubation at 37˚C for 45 min followed by heat inactivation at 80˚C for 15 min.
Multiplex SBE reaction was performed using 1 μL of purified PCR products, SBE primers (Supplementary Material 1) and a SNaPshot TM kit according to the manufacturer's instructions. The final extension products were purified with SAP-Recombinant (USB)
enzyme. Large batch of 5× PCR primer and 10× SBE primer stocks were prepared and aliquoted to provide all laboratories with the same primer mixtures. The specified bisulfite converted DNA input for the multiplex PCR of parts 2 and 3 was 10 ng; in part 4, the input amount was not suggested. Example protocols were provided to participating laboratories (Supplementary Material 1), but a choice was given regarding which PCR buffers and amplicon purification methods were to be used.
Capillary electrophoresis and analysis of DNA methylation profiles
In the organizing laboratory, the extension products were analyzed using the ABI PRISM 3130xl Genetic Analyzer and GeneScan software 3.1 (Applied Biosystems). In participating laboratories, samples were injected and run according to conditions of choice on various types of standard genetic analyzers (Supplementary material 2) . For the analysis of DNA methylation profiles, participating laboratories were requested to report peak heights observed from the electropherograms and to calculate percentage methylation values (0-100%) at each CpG site by dividing nucleotide G intensity (detection of unconverted methylated cytosine on the reverse strand) by nucleotide G plus nucleotide A intensity (detection of converted unmethylated cytosine on the reverse strand). Then, body fluid typing results were reported in reference to the electrophoretic results of SBE products in part 1.
Results and Discussion
Participating laboratories
Seven laboratories including the organizing laboratory participated in this exercise. The participating laboratories varied in experience with regard to DNA methylation analyses.
Two laboratories indicated they were beginners at DNA methylation testing; two other laboratories, advanced beginners; one laboratory, an experienced researcher; and two other laboratories, experts. The participating laboratories were also asked to complete a questionnaire describing the kits, chemicals, quantities and instrumentation they used (Supplementary material 2). The seven laboratories used four different kits for DNA extraction, five different quantification methods, two different kits for bisulfite conversion, two different PCR buffers for multiplex PCR, three different thermocyclers, three different genetic analyzers and three different analytical software and five different analytical settings.
The diversity of instrumentation and respective analysis tools emphasizes the importance of
12
such collaborative exercises in order to evaluate the robustness of implementation of methods in different laboratories.
Exercise tasks: parts 1 to 4
The collaborative exercise started with part 1, where purified SBE products are analyzed with capillary electrophoresis. Analysis of the final multiplex methylation SNaPshot products from various body fluid samples provided references to the following data interpretation and enabled adjustment of the genetic analyzer setting if necessary. Six of the seven laboratories reported very similar results in part 1 (Fig. 1 ). One laboratory (laboratory 4) had, on average, 4-fold higher peaks than the organizing laboratory with low non-specific peaks that seemed to be due to the use of higher injection settings. Because of failure in adjusting the genetic analyzer setting and unsuccessful enzyme treatment to purify PCR products in the subsequent parts 2-4 at laboratory 4, the results discussed in this report will only include data from the remaining six laboratories. The methylation percentages at each CpG site were similar among the laboratories, but two laboratories using an ABI PRISM 310 genetic analyzer showed somewhat lower methylation percentages. In addition, it seems that because two types of menstrual blood of which one had the same profile as vaginal fluid (menstrual blood type 1)
were provided as references in part 1, participating laboratories had difficulty in inferring the sample origin with the profile of vaginal fluid; in this case, some laboratories reported the origin of the sample to be either vaginal fluid or menstrual blood, while others reported it to
This article is protected by copyright. All rights reserved. In part 4, various body fluid samples with and without specified origin were provided.
Specimens were subjected to DNA extraction, quantification, bisulfite conversion and multiplex methylation SNaPshot reaction using various methodologies according to each there were variations in DNA methylation percentages among laboratories. Because these unexpected methylation signals were frequently at less than 10% methylation and sometimes lower than 100 rfu, we recommend that in the future an appropriate detection threshold in terms of rfu and percent of methylation, e.g., more than 100 rfu and 10% methylation, should be applied. As for the methylation variation, this is not an unexpected result given that the participating laboratories used a variety of methods and instrumentation. It is important to note that the seven CpGs used in this multiplex provide on-off signal variations in results that can alleviate the effect of methylation variation among laboratories. Because it is not possible to differentiate vaginal fluid and menstrual blood with the present multiplex methylation SNaPshot system, the addition of new menstrual blood-specific CpG markers to the multiplex system is needed for better identification of body fluids. In addition, with the use of two or more CpG markers for each target body fluid being preferred, it is evident that there is also a need to identify more CpGs that are specific to saliva. If possible, the multiplex system should be supplemented in the future with more CpG markers to have two or more CpGs for each body fluid and consequently increase the accuracy of the identification of body fluids.
While routine use of DNA methylation-based body fluid typing and identification assays may yet require further tests for sensitivity and specificity, this study demonstrates that methylation profiling can be successfully implemented in forensic laboratories once clear guidelines are set for data interpretation.
